High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.
J. Clin. Invest. L Lattanzi, et al. 101:2119
doi:10.1172/JCI1505 [Go to this article.]

Problems with a PDF?